These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9873451)

  • 1. Solid-phase synthesis of N-substituted amidinophenoxy pyridines as factor XA inhibitors.
    Mohan R; Yun W; Buckman BO; Liang A; Trinh L; Morrissey MM
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1877-82. PubMed ID: 9873451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activity of novel factor Xa inhibitors: 4-aryloxy substituents of 2,6-diphenoxypyridines.
    Ng HP; Buckman BO; Eagen KA; Guilford WJ; Kochanny MJ; Mohan R; Shaw KJ; Wu SC; Lentz D; Liang A; Trinh L; Ho E; Smith D; Subramanyam B; Vergona R; Walters J; White KA; Sullivan ME; Morrissey MM; Phillips GB
    Bioorg Med Chem; 2002 Mar; 10(3):657-66. PubMed ID: 11814853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides.
    Jia ZJ; Wu Y; Huang W; Goldman E; Zhang P; Woolfrey J; Wong P; Huang B; Sinha U; Park G; Reed A; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1651-5. PubMed ID: 12039583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
    Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
    Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory solid-phase synthesis of factor Xa inhibitors: discovery and application of p3-heterocyclic amides as novel types of non-basic arginine surrogates.
    Ho JZ; Levy OE; Gibson TS; Nguyen K; Semple JE
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3459-64. PubMed ID: 10617091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors.
    Su T; Wu Y; Doughan B; Jia ZJ; Woolfrey J; Huang B; Wong P; Park G; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2947-50. PubMed ID: 11677132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity.
    Guertin KR; Gardner CJ; Klein SI; Zulli AL; Czekaj M; Gong Y; Spada AP; Cheney DL; Maignan S; Guilloteau JP; Brown KD; Colussi DJ; Chu V; Heran CL; Morgan SR; Bentley RG; Dunwiddie CT; Leadley RJ; Pauls HW
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1671-4. PubMed ID: 12039587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel benzo-fused lactam scaffolds as factor Xa inhibitors.
    Tamura SY; Goldman EA; Bergum PW; Semple JE
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2573-8. PubMed ID: 10498211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J; Fevig JM; Stouten PF; Alexander RS; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1253-6. PubMed ID: 10866393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors.
    Heinelt U; Herok S; Matter H; Wildgoose P
    Bioorg Med Chem Lett; 2001 Jan; 11(2):227-30. PubMed ID: 11206465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A general synthesis of 1-aryl carbamoyl-2-alkyl-4-aryl substituted semicarbazides as nonbasic factor Xa inhibitors.
    Mederski WW; Germann M
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3715-8. PubMed ID: 14552764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa.
    Adler M; Davey DD; Phillips GB; Kim SH; Jancarik J; Rumennik G; Light DR; Whitlow M
    Biochemistry; 2000 Oct; 39(41):12534-42. PubMed ID: 11027132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.
    Phillips GB; Buckman BO; Davey DD; Eagen KA; Guilford WJ; Hinchman J; Ho E; Koovakkat S; Liang A; Light DR; Mohan R; Ng HP; Post JM; Shaw KJ; Smith D; Subramanyam B; Sullivan ME; Trinh L; Vergona R; Walters J; White K; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 1998 Sep; 41(19):3557-62. PubMed ID: 9733480
    [No Abstract]   [Full Text] [Related]  

  • 15. A four component coupling strategy for the synthesis of D-phenylglycinamide-derived non-covalent factor Xa inhibitors.
    Sheehan SM; Masters JJ; Wiley MR; Young SC; Liebeschuetz JW; Jones SD; Murray CW; Franciskovich JB; Engel DB; Weber WW; Marimuthu J; Kyle JA; Smallwood JK; Farmen MW; Smith GF
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2255-9. PubMed ID: 12824013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
    Guilford WJ; Shaw KJ; Dallas JL; Koovakkat S; Lee W; Liang A; Light DR; McCarrick MA; Whitlow M; Ye B; Morrissey MM
    J Med Chem; 1999 Dec; 42(26):5415-25. PubMed ID: 10639283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups.
    Phillips G; Guilford WJ; Buckman BO; Davey DD; Eagen KA; Koovakkat S; Liang A; McCarrick M; Mohan R; Ng HP; Pinkerton M; Subramanyam B; Ho E; Trinh L; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 2002 Jun; 45(12):2484-93. PubMed ID: 12036356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of aminophenol-based factor Xa inhibitors.
    Wu S; Guilford WJ; Chou YL; Griedel BD; Liang A; Sakata S; Shaw KJ; Trinh L; Xu W; Zhao Z; Morrissey MM
    Bioorg Med Chem Lett; 2002 May; 12(9):1307-10. PubMed ID: 11965377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonbenzamidine compounds as selective factor Xa inhibitors.
    He W; Hanney B; Myers MR; Spada AP; Brown K; Colussi D; Chu V
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1737-9. PubMed ID: 10937736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors.
    Zhang P; Zuckett JF; Woolfrey J; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach S; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1657-61. PubMed ID: 12039584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.